ZLAB

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Zai Lab Ltd

NASDAQ | ZLAB

29.09

USD

$0.00

(

0.00%

)

At Close (As of Oct 22, 2025)

$3.24B

Market Cap

-

P/E Ratio

-2

EPS

$44.34

52 Week High

$23.82

52 Week Low

HEALTHCARE

Sector

ZLAB Chart

Recent Chart
Price Action

ZLAB Technicals

Tags:

ZLAB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $251M
Total Revenue $399M
Cost Of Revenue $148M
Costof Goods And Services Sold $148M
Operating Income -$282M
Selling General And Administrative $299M
Research And Development $235M
Operating Expenses $533M
Investment Income Net -
Net Interest Income $35M
Interest Income $37M
Interest Expense $2.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $20M
Income Before Tax -$257M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$257M
Comprehensive Income Net Of Tax -
Ebit -$255M
Ebitda -$235M
Net Income -$257M

Revenue & Profitability

Earnings Performance

ZLAB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.2B
Total Current Assets $1.1B
Cash And Cash Equivalents At Carrying Value $450M
Cash And Short Term Investments $450M
Inventory $40M
Current Net Receivables $89M
Total Non Current Assets $135M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $59M
Intangible Assets Excluding Goodwill $59M
Goodwill -
Investments -
Long Term Investments $3.1M
Short Term Investments $330M
Other Current Assets $142M
Other Non Current Assets -
Total Liabilities $345M
Total Current Liabilities $299M
Current Accounts Payable $101M
Deferred Revenue -
Current Debt -
Short Term Debt $140M
Total Non Current Liabilities $45M
Capital Lease Obligations $22M
Long Term Debt -
Current Long Term Debt $132M
Long Term Debt Noncurrent -
Short Long Term Debt Total $153M
Other Current Liabilities $54M
Other Non Current Liabilities $325K
Total Shareholder Equity $841M
Treasury Stock -
Retained Earnings -$2.5B
Common Stock $7K
Common Stock Shares Outstanding $99M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$215M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $12M
Capital Expenditures $62M
Change In Receivables -
Change In Inventory $3.9M
Profit Loss -
Cashflow From Investment -$375M
Cashflow From Financing $350M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$257M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $251M
Total Revenue $399M
Cost Of Revenue $148M
Costof Goods And Services Sold $148M
Operating Income -$282M
Selling General And Administrative $299M
Research And Development $235M
Operating Expenses $533M
Investment Income Net -
Net Interest Income $35M
Interest Income $37M
Interest Expense $2.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $20M
Income Before Tax -$257M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$257M
Comprehensive Income Net Of Tax -
Ebit -$255M
Ebitda -$235M
Net Income -$257M

ZLAB News

ZLAB Profile

Zai Lab Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Zai Lab Limited (ZLAB) is a prominent biopharmaceutical company headquartered in Shanghai, China, dedicated to the discovery, development, and commercialization of innovative therapies targeting cancer, autoimmune disorders, and infectious diseases. With a robust pipeline of novel drug candidates and a strategic focus on fostering global partnerships, Zai Lab is well-equipped to meet the significant unmet medical needs in China and internationally. The company is positioned to leverage the rapid growth of the biopharmaceutical market, underscoring its commitment to enhancing patient outcomes through cutting-edge research and development.

YYAI
+133.74%
$0.18
BYND
-1.10%
$3.58
YDKG
+19.92%
$0.06
BURU
+24.34%
$0.36
VHAI
0.00%
$0.00
ADAP
+49.17%
$0.07
F
-1.03%
$12.43
BENF
+205.95%
$1.49
AIRE
-1.92%
$0.71
CGBS
-39.47%
$0.03
NVDA
-0.48%
$180.28
BITF
-12.24%
$3.94
DNUT
+8.62%
$4.03
RGTI
-9.85%
$36.06
PLUG
-6.41%
$2.92
WTO
+10.81%
$0.07
DNN
0.00%
$2.72
T
-1.91%
$25.55
TLRY
-2.02%
$1.45
INTC
-3.14%
$36.92
TSLA
-0.82%
$438.97
QBTS
-15.22%
$27.29
EPWK
+13.34%
$0.08
RIG
+3.32%
$3.42
SOFI
-5.42%
$27.19
AXDX
-61.36%
$0.03
NOK
-0.53%
$5.55
ACHR
-4.82%
$10.86
CIFR
-10.87%
$16.11
RANI
-15.26%
$2.41
GPUS
+4.79%
$0.38
BBD
0.00%
$3.30
RF
-1.02%
$24.11
AMD
-3.27%
$230.23
IXHL
-2.46%
$0.34
CAN
-12.56%
$1.70
AAL
-2.10%
$12.09
QS
-12.50%
$13.58
PLTR
-3.31%
$175.49
AREB
+72.00%
$2.15
ETHD
+10.21%
$4.09
BNBX
+40.35%
$4.80
NVTS
-9.48%
$13.60
ONDS
-6.25%
$6.74
IREN
-6.09%
$51.83
NIO
+0.58%
$6.84
WBD
+0.98%
$20.53
ABEV
-0.90%
$2.20
QUBT
-7.06%
$14.87
HPE
-0.77%
$23.09
VALE
+2.21%
$11.52
ALEC
-49.84%
$1.61
PFE
-0.52%
$24.72
GRAB
+0.35%
$5.62
IONZ
+13.38%
$4.66
APLD
-5.90%
$30.62
RXRX
-5.89%
$5.75
AAPL
-1.64%
$258.45
BTBT
-7.23%
$3.59
AMZN
-1.83%
$217.95
CJET
+21.50%
$0.09
SOUN
-2.57%
$17.76
JOBY
-3.91%
$15.47
GPRO
+5.00%
$2.31
RR
-10.12%
$5.05
LAES
-11.47%
$5.40
RIVN
-2.12%
$12.92
AVDL
+3.66%
$18.52
SNAP
-1.01%
$7.77
WULF
-3.99%
$12.61
MARA
-4.58%
$19.14
UUUU
+10.22%
$22.74
RMBL
+60.50%
$3.21
IONQ
-6.80%
$55.45
SMR
-9.51%
$34.72
ADD
-25.47%
$0.05
DVLT
-15.41%
$2.14
HOOD
-3.50%
$127.22
BMNR
-7.36%
$48.03
CLSK
-10.17%
$16.86
BTG
+0.57%
$5.21
FLWS
-14.75%
$4.38
AMC
-4.84%
$2.75
GOOGL
+0.49%
$251.69
SRM
+53.27%
$10.30
BAC
-0.81%
$51.10
OKLO
-13.85%
$120.12
SMCI
-4.23%
$52.50
RGTZ
+19.73%
$18.69
PBR
+1.47%
$11.73
VIVK
+7.79%
$0.24
NDLS
+33.01%
$0.95
CUTR
-10.19%
$0.09
WLGS
-5.57%
$0.04
GSIT
+18.69%
$12.89
ASTS
-9.23%
$71.34
JBLU
-0.85%
$4.62
EOSE
-7.60%
$15.06
UAMY
+5.81%
$13.11
IBIO
+25.22%
$1.39
YYAI
+133.74%
$0.18
BYND
-1.10%
$3.58
YDKG
+19.92%
$0.06
BURU
+24.34%
$0.36
VHAI
0.00%
$0.00
ADAP
+49.17%
$0.07
F
-1.03%
$12.43
BENF
+205.95%
$1.49
AIRE
-1.92%
$0.71
CGBS
-39.47%
$0.03
NVDA
-0.48%
$180.28
BITF
-12.24%
$3.94
DNUT
+8.62%
$4.03
RGTI
-9.85%
$36.06
PLUG
-6.41%
$2.92
WTO
+10.81%
$0.07
DNN
0.00%
$2.72
T
-1.91%
$25.55
TLRY
-2.02%
$1.45
INTC
-3.14%
$36.92
TSLA
-0.82%
$438.97
QBTS
-15.22%
$27.29
EPWK
+13.34%
$0.08
RIG
+3.32%
$3.42
SOFI
-5.42%
$27.19
AXDX
-61.36%
$0.03
NOK
-0.53%
$5.55
ACHR
-4.82%
$10.86
CIFR
-10.87%
$16.11
RANI
-15.26%
$2.41
GPUS
+4.79%
$0.38
BBD
0.00%
$3.30
RF
-1.02%
$24.11
AMD
-3.27%
$230.23
IXHL
-2.46%
$0.34
CAN
-12.56%
$1.70
AAL
-2.10%
$12.09
QS
-12.50%
$13.58
PLTR
-3.31%
$175.49
AREB
+72.00%
$2.15
ETHD
+10.21%
$4.09
BNBX
+40.35%
$4.80
NVTS
-9.48%
$13.60
ONDS
-6.25%
$6.74
IREN
-6.09%
$51.83
NIO
+0.58%
$6.84
WBD
+0.98%
$20.53
ABEV
-0.90%
$2.20
QUBT
-7.06%
$14.87
HPE
-0.77%
$23.09
VALE
+2.21%
$11.52
ALEC
-49.84%
$1.61
PFE
-0.52%
$24.72
GRAB
+0.35%
$5.62
IONZ
+13.38%
$4.66
APLD
-5.90%
$30.62
RXRX
-5.89%
$5.75
AAPL
-1.64%
$258.45
BTBT
-7.23%
$3.59
AMZN
-1.83%
$217.95
CJET
+21.50%
$0.09
SOUN
-2.57%
$17.76
JOBY
-3.91%
$15.47
GPRO
+5.00%
$2.31
RR
-10.12%
$5.05
LAES
-11.47%
$5.40
RIVN
-2.12%
$12.92
AVDL
+3.66%
$18.52
SNAP
-1.01%
$7.77
WULF
-3.99%
$12.61
MARA
-4.58%
$19.14
UUUU
+10.22%
$22.74
RMBL
+60.50%
$3.21
IONQ
-6.80%
$55.45
SMR
-9.51%
$34.72
ADD
-25.47%
$0.05
DVLT
-15.41%
$2.14
HOOD
-3.50%
$127.22
BMNR
-7.36%
$48.03
CLSK
-10.17%
$16.86
BTG
+0.57%
$5.21
FLWS
-14.75%
$4.38
AMC
-4.84%
$2.75
GOOGL
+0.49%
$251.69
SRM
+53.27%
$10.30
BAC
-0.81%
$51.10
OKLO
-13.85%
$120.12
SMCI
-4.23%
$52.50
RGTZ
+19.73%
$18.69
PBR
+1.47%
$11.73
VIVK
+7.79%
$0.24
NDLS
+33.01%
$0.95
CUTR
-10.19%
$0.09
WLGS
-5.57%
$0.04
GSIT
+18.69%
$12.89
ASTS
-9.23%
$71.34
JBLU
-0.85%
$4.62
EOSE
-7.60%
$15.06
UAMY
+5.81%
$13.11
IBIO
+25.22%
$1.39
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.